Article Type
Changed
Mon, 10/07/2024 - 10:12
Display Headline
Eyelid Dermatitis: Common Patterns and Contact Allergens

Eyelid dermatitis is a common dermatologic concern representing a broad group of inflammatory dermatoses and typically presenting as eczematous lesions on the eyelids.1 One of the most common causes of eyelid dermatitis is thought to be allergic contact dermatitis (ACD), a type IV delayed hypersensitivity reaction caused by exposure to external allergens.2 Although ACD can occur anywhere on the body, dermatitis on the face and eyelids is quite common.1,2 This article aims to explore the clinical manifestation, evaluation, and management of eyelid ACD.

Pathophysiology of Eyelid ACD

Studies have shown that ACD is the most common cause of eyelid dermatitis, estimated to account for 46% to 72% of cases worldwide.3-6 Allergic contact dermatitis is a T cell–mediated type IV hypersensitivity reaction to external antigens that manifests as eczematous lesions at the site of contact with the allergen that may spread.7 Allergic contact dermatitis is a common condition, and it is estimated that at least 20% of the general worldwide population has a contact allergy.8,9 Histologically, ACD manifests as spongiotic dermatitis, though this is not unique and also may be seen in atopic dermatitis (AD) and irritant contact dermatitis.2 Allergic contact dermatitis is diagnosed via epicutaneous patch testing, and treatment involves allergen avoidance with or without adjuvant topical and/or systemic immunomodulatory treatments.7

The eyelids are uniquely prone to the development of ACD given their thinner epidermis and increased susceptibility to irritation. They frequently are exposed to allergens through the direct topical route as well as indirectly via airborne exposure, rinse-down products (eg, shampoos), and substances transferred from an individual’s own hands. The occluded skin folds of the eyelids facilitate increased exposure to trapped allergens.10,11 Additionally, the skin of the eyelids is thin, flexible, highly vascularized, and lacking in subcutaneous tissue, making this area more susceptible to antigen penetration than other locations on the body.1,2,10,12,13

Clinical Manifestations

Eyelid ACD is more common in females than males, which is thought to be related to increased use of cosmetics and fragrances.1,3,12,14-16 Clinical manifestations may resemble eczematous papules and plaques.1 Eyelid ACD commonly spreads beyond the eyelid margin, which helps to differentiate it from AD and irritant contact dermatitis. Symptoms of ACD on the eyelids typically include pruritus, redness, swelling, tearing, scaling, and pain.2 Persistent untreated eyelid dermatitis can lead to eyelash loss, damage to meibomian glands, and hyperpigmentation.2,17,18

Patterns of Eyelid ACD

Allergic contact dermatitis on the eyelids can occur due to direct application of allergens onto the skin of the eyelids, runoff of products from the hair/scalp (eg, shampoo), transfer of allergens from the hands, or contact with airborne allergens.1,2,11,12 Some reports have suggested that eyelid ACD more often is caused by products applied to the scalp or face rather than those applied directly to the eyelids.11 Because the scalp and face are less reactive to contact allergens, in some cases the eyelids may be the only affected site.10,12,13

The specific pattern of dermatitis on or around the eyelids can provide clues to the allergenic source. Dermatitis present around the eyelids and periorbital region with involvement of the bilateral upper and lower eyelids suggests direct exposure to a contact allergen, such as makeup or other cosmetic products.1 Unilateral involvement of only 1 eyelid can occur with ectopic transfer of allergens from the hands or nails.1,19 Involvement of the fingers or nails in addition to the eyelids may further suggest ectopic transfer, such as from allergens in nail polish.10 Unilateral eyelid dermatitis also could be caused by unique exposures such as a microscope or camera eyepiece.19 Distribution around the lower eyelids and upper cheeks is indicative of a drip or runoff pattern, which may result from an ophthalmic solution such as eye drops or contact lens solution.1,19 Finally, dermatitis affecting the upper eyelids along with the nasolabial folds and upper chest may suggest airborne contact dermatitis to fragrances or household cleaning products.1,11

Common Culprits of Eyelid ACD

Common causes of eyelid ACD include cosmetic products, ophthalmic medications, nail lacquers, and jewelry.10,13,20 Within the broader category of cosmetics, allergens may be found in makeup and makeup removers, cosmetic applicators and brushes, soaps and cleansers, creams and sunscreens, antiaging products, hair products, nail polish and files, and hair removal products, among many others.10,13,16,20 Additionally, ophthalmologic and topical medications are common sources of ACD, including eyedrops, contact lens solution, and topical antibiotics.10,13,21 Costume jewelry commonly contains allergenic metals, which also can be found in eyelash curlers, eyeglasses, toys, and other household items.22,23 Finally, contact allergens can be found in items such as goggles, gloves, textiles, and a variety of other occupational and household exposures.

Allergic contact dermatitis of the eyelids occurs predominantly—but not exclusively—in females.16,20,24 This finding has been attributed to the traditionally greater use of cosmetics and fragrances among women; however, the use of skin care products among men is increasing, and recent studies have shown the eyelids to be a common location of facial contact dermatitis among men.16,24 Although eyelid dermatitis has not been specifically analyzed by sex, a retrospective analysis of 1332 male patients with facial dermatitis found the most common sites to be the face (not otherwise specified)(48.9%), eyelids (23.5%), and lips (12.6%). In this cohort, the most common allergens were surfactants in shampoos and paraphenylenediamine in hair dyes.24

Common Allergens

Common contact allergens among patients with ACD of the eyelids include metals, fragrances, preservatives, acrylates, and topical medications.3,10,16,20,25-27 Sources of common contact allergens are reviewed in Table 1.

Metals—Metals are among the most common causes of ACD overall, and nickel frequently is reported as one of the top contact allergens in patients with eyelid dermatitis.16,27 A retrospective analysis of 2332 patients with eyelid dermatitis patch tested by the North American Contact Dermatitis Group from 1994 to 2016 found that 18.6% of patients with eyelid ACD had a clinically relevant nickel allergy. Sources of nickel exposure include jewelry, grooming devices, makeup and makeup applicators, and eyelash curlers, as well as direct transfer from the hands after contact with consumer products.16

Other metals that can cause ACD include cobalt (found in similar products to nickel) and gold. Gold often is associated with eyelid dermatitis, though its clinical relevance has been debated, as gold is a relatively inert metal that rarely is present in eye cosmetics and its ions are not displaced from objects and deposited on the skin via sweat in the same way as nickel.4,16,20,28-30 Despite this, studies have shown that gold is a common positive patch test reaction among patients with eyelid dermatitis, even in patients with no dermatitis at the site of contact with gold jewelry.20,29,31 Gold has been reported to be the most common allergen causing unilateral eyelid dermatitis via ectopic transfer.16,19,20,29 It has been proposed that titanium dioxide, present in many cosmetics and sunscreens, displaces gold allowing its release from jewelry, thereby liberating the fine gold ions and allowing them to desposit on the face and eyelids.30,31 Given the uncertain clinical relevance of positive patch test reactions to gold, Warshaw at al16 recommend a 2- to 3-month trial of gold jewelry avoidance to establish relevance, and Ehrlich and Gold29 noted that avoidance of gold leads to improvement.

Fragrances—Fragrances represent a broad category of naturally occurring and man-made components that often are combined to produce a desired scent in personal care products.32 Essential oils and botanicals are both examples of natural fragrances.33 Fragrances are found in numerous products including makeup, hair products, and household cleaning supplies and represent some of the most common contact allergens.32 Common fragrance allergens include fragrance mixes I and II, hydroperoxides of linalool, and balsam of Peru.12,32,34 Allergic contact dermatitis to fragrances typically manifests on the eyelids, face, or hands.33 Several studies have found fragrances to be among the top contact allergens in patients with eyelid dermatitis.3,12,20,25,34 Patch testing for fragrance allergy may include baseline series, supplemental fragrance series, and personal care products.32,35

Preservatives—Preservatives, including formaldehyde and formaldehyde releasers (eg, quaternium-15 and ­bronopol) and methylchloroisothiazolinone/­methylisothiazolinone, may be found in personal care products such as makeup, makeup removers, emollients, shampoos, hair care products, and ophthalmologic solutions and are among the most common cosmetic sources of ACD.13,36-39 Preservatives are among the top allergens causing eyelid dermatitis.20 In particular, patch test positivity rates to methylchloroisothiazolinone/methylisothiazolinone have been increasing in North America.40 Sensitization to preservatives may occur through direct skin contact or transfer from the hands.41

Acrylates—Acrylates are compounds derived from acrylic acid that may be found in acrylic and gel nails, eyelash extensions, and other adhesives and are frequent causes of eyelid ACD.4,10,42 Acrylate exposure may be cosmetic among consumers or occupational (eg, aestheticians).42,43 Acrylates on the nails may cause eyelid dermatitis via ectopic transfer from the hands and also may cause periungual dermatitis manifesting as nail bed erythema.10 Hydroxyethyl methacrylate is one of the more common eyelid ACD allergens, and studies have shown increasing prevalence of positive reaction rates to hydroxyethylmethacrylate.10,44Topical Medications—Contact allergies to topical medications are quite common, estimated to occur in 10% to 17% of patients undergoing patch testing.45 Both active and inactive ingredients of topical medications may be culprits in eyelid ACD. The most common topical medication allergens include antibiotics, steroids, local anesthetics, and nonsteroidal anti-inflammatory drugs.45 Topical antibiotics such as neomycin and bacitracin represent some of the most common causes of eyelid dermatitis4,10 and may be found in a variety of products, including antibacterial ointments and eye drops.1 Many ophthalmologic medications also contain corticosteroids, with the most common allergenic steroids being tixocortol pivalate (a marker for hydrocortisone allergy) and budesonide.10,20 Topical steroids pose a particular dilemma, as they can be either the source of or a treatment for ACD.10 Eye drops also may contain anesthetics, β-blockers, and antihistamines, as well as the preservative benzalkonium chloride, all of which may be contact allergens.21,39

Differential Diagnosis of Eyelid Dermatitis

Although ACD is reported to be the most common cause of eyelid dermatitis, the differential diagnosis is broad, including endogenous inflammatory dermatoses and exogenous exposures (Table 2). Symptoms of eyelid ACD can be nonspecific (eg, erythema, pruritus), making diagnosis challenging.46

Atopic dermatitis represents another common cause of eyelid dermatitis, accounting for 14% to 39.5% of cases.3-5,49Atopic dermatitis of the eyelids classically manifests with lichenification of the medial aspects of the eyelids.50 Atopic dermatitis and ACD may be difficult to distinguish, as the 2 conditions appear clinically similar and can develop concomitantly.51 Additionally, atopic patients are likely to have comorbid allergic rhinitis and sensitivity to environmental allergens, which may lead to chronic eye scratching and lichenification.1,51 Clinical features of eyelid dermatitis suggesting allergic rhinitis and likely comorbid AD include creases in the lower eyelids (Dennie-Morgan lines) and periorbital hyperpigmentation (known as the allergic shiner) due to venous congestion.1,52

Seborrheic dermatitis is an inflammatory reaction to Malassezia yeast that occurs in sebaceous areas such as the groin, scalp, eyebrows, eyelids, and nasolabial folds.1,53,54

Irritant contact dermatitis, a nonspecific inflammatory reaction caused by direct cell damage from external irritants, also may affect the eyelids and appear similar to ACD.1 It typically manifests with a burning or stinging sensation, as opposed to pruritus, and generally develops and resolves more rapidly than ACD.1 Personal care products are common causes of eyelid irritant contact dermatitis.16

Patch Testing for Eyelid ACD

The gold standard for diagnosis of ACD is patch testing, outlined by the International Contact Dermatitis Research Group.55-57 Patch testing generally is performed with standardized panels of allergens and can be customized either with supplemental panels based on unique exposures or with the patient’s own personal care products to increase the sensitivity of testing. Therefore, a thorough history is crucial to identifying potential allergens in a patient’s environment.

False negatives are possible, as the skin on the back may be thicker and less sensitive than the skin at the location of dermatitis.2,58 This is particularly relevant when using patch testing to diagnose ACD of the eyelids, where the skin is particularly thin and sensitive.2 Additionally, ingredients of ophthalmic medications are known to have an especially high false-negative rate with standard patch testing and may require repeated testing with higher drug concentrations or modified patch testing procedures (eg, open testing, scratch-patch testing).1,59

Treatment

Management of ACD involves allergen avoidance, typically dictated by patch test results.10 Allergen avoidance may be facilitated using online resources such as the Contact Allergen Management Program (https://www.acdscamp.org/) created by the American Contact Dermatitis Society.10,18 Patient counseling following patch testing is crucial to educating patients about sources of potential allergen exposures and strategies for avoidance. In the case of eyelid dermatitis, it is particularly important to consider exposure to airborne allergens such as fragrances.16 Fragrance avoidance is uniquely difficult, as labelling standards in the United States currently do not require disclosure of specific fragrance components.33 Additionally, products labelled as unscented may still contain fragrances. As such, some patients with fragrance allergy may need to carefully avoid all products containing fragrances.33

In addition to allergen avoidance, eyelid ACD may be treated with topical medications (eg, steroids, calcineurin inhibitors, Janus kinase inhibitors); however, these same topical medications also can cause ACD due to some ingredients such as propylene glycol.10 Topical steroids should be used with caution on the eyelids given the risk for atrophy, cataracts, and glaucoma.1

Final Interpretation

Eyelid dermatitis is a common dermatologic condition most frequently caused by ACD due to exposure to allergens in cosmetic products, ophthalmic medications, nail lacquers, and jewelry, among many other potential sources. The most common allergens causing eyelid dermatitis include metals (particularly nickel), fragrances, preservatives, acrylates, and topical medications. Eyelid ACD is diagnosed via patch testing, and the mainstay of treatment is strict allergen avoidance. Patient counseling is vital for successful allergen avoidance and resolution of eyelid ACD.

References
  1. Hine AM, Waldman RA, Grzybowski A, et al. Allergic disorders of the eyelid. Clin Dermatol. 2023;41:476-480. doi:10.1016/j.clindermatol.2023.08.002
  2. Turkiewicz M, Shah A, Yang YW, et al. Allergic contact dermatitis of the eyelids: an interdisciplinary review. Ocul Surf. 2023;28:124-130. doi:10.1016/j.jtos.2023.03.001
  3. Valsecchi R, Imberti G, Martino D, et al. Eyelid dermatitis: an evaluation of 150 patients. Contact Dermatitis. 1992;27:143-147. doi:10.1111/j.1600-0536.1992.tb05242.x
  4. Guin JD. Eyelid dermatitis: experience in 203 cases. J Am Acad Dermatol. 2002;47:755-765. doi:10.1067/mjd.2002.122736
  5. Nethercott JR, Nield G, Holness DL. A review of 79 cases of eyelid dermatitis. J Am Acad Dermatol. 1989;21(2 pt 1):223-230. doi:10.1016/s0190-9622(89)70165-1
  6. Shah M, Lewis FM, Gawkrodger DJ. Facial dermatitis and eyelid dermatitis: a comparison of patch test results and final diagnoses. Contact Dermatitis. 1996;34:140-141. doi:10.1111/j.1600-0536.1996.tb02148.x
  7. Brites GS, Ferreira I, Sebastião AI, et al. Allergic contact dermatitis: from pathophysiology to development of new preventive strategies. Pharmacol Res. 2020;162:105282. doi:10.1016/j.phrs.2020.105282
  8. Alinaghi F, Bennike NH, Egeberg A, et al. Prevalence of contact allergy in the general population: a systematic review and meta-analysis. Contact Dermatitis. 2019;80:77-85. doi:10.1111/cod.13119
  9. Adler BL, DeLeo VA. Allergic contact dermatitis. JAMA Dermatol. 2021;157:364. doi:10.1001/jamadermatol.2020.5639
  10. Huang CX, Yiannias JA, Killian JM, et al. Seven common allergen groups causing eyelid dermatitis: education and avoidance strategies. Clin Ophthalmol Auckl NZ. 2021;15:1477-1490. doi:10.2147/OPTH.S297754
  11. Rozas-Muñoz E, Gamé D, Serra-Baldrich E. Allergic contact dermatitis by anatomical regions: diagnostic clues. Actas Dermo-Sifiliográficas Engl Ed. 2018;109:485-507. doi:10.1016/j.adengl.2018.05.016
  12. Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis. 2006;55:280-285. doi:10.1111/j.1600-0536.2006.00927.x
  13. Wolf R, Orion E, Tüzün Y. Periorbital (eyelid) dermatides. Clin Dermatol. 2014;32:131-140. doi:10.1016/j.clindermatol.2013.05.035
  14. Ockenfels HM, Seemann U, Goos M. Contact allergy in patients with periorbital eczema: an analysis of allergens. data recorded by the Information Network of the Departments of Dermatology. Dermatol Basel Switz. 1997;195:119-124. doi:10.1159/000245712
  15. Landeck L, John SM, Geier J. Periorbital dermatitis in 4779 patients—patch test results during a 10-year period. Contact Dermatitis. 2014;70:205-212. doi:10.1111/cod.12157
  16. Warshaw EM, Voller LM, Maibach HI, et al. Eyelid dermatitis in patients referred for patch testing: retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. J Am Acad Dermatol. 2021;84:953-964. doi:10.1016/j.jaad.2020.07.020
  17. McMonnies CW. Management of chronic habits of abnormal eye rubbing. Contact Lens Anterior Eye. 2008;31:95-102. doi:10.1016/j.clae.2007.07.008
  18. Chisholm SAM, Couch SM, Custer PL. Etiology and management of allergic eyelid dermatitis. Ophthal Plast Reconstr Surg. 2017;33:248-250. doi:10.1097/IOP.0000000000000723
  19. Lewallen R, Feldman S, eds. Regional atlas of contact dermatitis. The Dermatologist. Accessed April 22, 2024. https://s3.amazonaws.com/HMP/hmp_ln/imported/Regional%20Atlas%20of%20Contact%20Dermatitis%20Book_lr.pdf
  20. Rietschel RL, Warshaw EM, Sasseville D, et al. Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period. Dermat Contact Atopic Occup Drug. 2007;18:78-81. doi:10.2310/6620.2007.06041
  21. Mughal AA, Kalavala M. Contact dermatitis to ophthalmic solutions. Clin Exp Dermatol. 2012;37:593-597; quiz 597-598. doi:10.1111/j.1365-2230.2012.04398.x
  22. Goossens A. Contact allergic reactions on the eyes and eyelids. Bull Soc Belge Ophtalmol. 2004;292:11-17.
  23. Silverberg NB, Pelletier JL, Jacob SE, et al. Nickel allergic contact dermatitis: identification, treatment, and prevention. Pediatrics. 2020;145:E20200628. doi:10.1542/peds.2020-0628
  24. Warshaw EM, Schlarbaum JP, Maibach HI, et al. Facial dermatitis in male patients referred for patch testing. JAMA Dermatol. 2020;156:79-84. doi:10.1001/jamadermatol.2019.3531
  25. Wenk KS, Ehrlich A. Fragrance series testing in eyelid dermatitis. Dermatitis. 2012;23:22-26. doi:10.1097/DER.0b013e31823d180f
  26. Crouse L, Ziemer C, Ziemer C, et al. Trends in eyelid dermatitis. Dermat Contact Atopic Occup Drug. 2018;29:96-97. doi:10.1097/DER.0000000000000338
  27. Yazdanparast T, Nassiri Kashani M, Shamsipour M, et al. Contact allergens responsible for eyelid dermatitis in adults. J Dermatol. 2024;51:691-695. doi:10.1111/1346-8138.17140
  28. Fowler J, Taylor J, Storrs F, et al. Gold allergy in North America. Am J Contact Dermat. 2001;12:3-5.
  29. Ehrlich A, Belsito DV. Allergic contact dermatitis to gold. Cutis. 2000;65:323-326.
  30. Danesh M, Murase JE. Titanium dioxide induces eyelid dermatitis in patients allergic to gold. J Am Acad Dermatol. 2015;73:E21. doi:10.1016/j.jaad.2015.03.046
  31. Katta R. Common misconceptions in contact dermatitis counseling. Dermatol Online J. 2008;14:2.
  32. De Groot AC. Fragrances: contact allergy and other adverse effects. Dermatitis. 2020;31:13-35. doi:10.1097/DER.0000000000000463
  33. Reeder MJ. Allergic contact dermatitis to fragrances. Dermatol Clin. 2020;38:371-377. doi:10.1016/j.det.2020.02.009
  34. Warshaw EM, Zhang AJ, DeKoven JG, et al. Epidemiology of nickel sensitivity: retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014. J Am Acad Dermatol. 2019;80:701-713. doi:10.1016/j.jaad.2018.09.058
  35. Schalock PC, Dunnick CA, Nedorost S, et al. American Contact Dermatitis Society core allergen series: 2020 update. Dermatitis. 2020;31:279-282. doi:10.1097/DER.0000000000000621
  36. Yim E, Baquerizo Nole KL, Tosti A. Contact dermatitis caused by preservatives. Dermatitis. 2014;25:215-231. doi:10.1097/DER.0000000000000061
  37. Alani JI, Davis MDP, Yiannias JA. Allergy to cosmetics. Dermatitis. 2013;24:283-290. doi:10.1097/DER.0b013e3182a5d8bc
  38. Hamilton T, de Gannes GC. Allergic contact dermatitis to preservatives and fragrances in cosmetics. Skin Ther Lett. 2011;16:1-4.
  39. Ashton SJ, Mughal AA. Contact dermatitis to ophthalmic solutions: an update. Dermat Contact Atopic Occup Drug. 2023;34:480-483. doi:10.1089/derm.2023.0033
  40. Reeder MJ, Warshaw E, Aravamuthan S, et al. Trends in the prevalence of methylchloroisothiazolinone/methylisothiazolinone contact allergy in North America and Europe. JAMA Dermatol. 2023;159:267-274. doi:10.1001/jamadermatol.2022.5991
  41. Herro EM, Elsaie ML, Nijhawan RI, et al. Recommendations for a screening series for allergic contact eyelid dermatitis. Dermatitis. 2012;23:17-21. doi:10.1097/DER.0b013e31823d191f
  42. Kucharczyk M, Słowik-Rylska M, Cyran-Stemplewska S, et al. Acrylates as a significant cause of allergic contact dermatitis: new sources of exposure. Adv Dermatol Allergol Dermatol Alergol. 2021;38:555-560. doi:10.5114/ada.2020.95848
  43. Rodriguez I, George SE, Yu J, et al. Tackling acrylate allergy: the sticky truth. Cutis. 2023;112:282-286. doi:10.12788/cutis.0909
  44. DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group Patch Test Results: 2019–2020. Dermatitis. 2023;34:90-104. doi:10.1089/derm.2022.29017.jdk
  45. de Groot A. Allergic contact dermatitis from topical drugs: an overview. Dermatitis. 2021;32:197-213. doi:10.1097/DER.0000000000000737
  46. Zug KA, Palay DA, Rock B. Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol. 1996;40:293-306. doi:10.1016/s0039-6257(96)82004-2
  47. Beltrani VS. Eyelid dermatitis. Curr Allergy Asthma Rep. 2001;1:380-388. doi:10.1007/s11882-001-0052-0
  48. Hirji SH, Maeng MM, Tran AQ, et al. Cutaneous T-cell lymphoma of the eyelid masquerading as dermatitis. Orbit Amst Neth. 2021;40:75-78. doi:10.1080/01676830.2020.1739080
  49. Svensson A, Möller H. Eyelid dermatitis: the role of atopy and contact allergy. Contact Dermatitis. 1986;15:178-182. doi:10.1111/j.1600-0536.1986.tb01321.x
  50. Papier A, Tuttle DJ, Mahar TJ. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2007;76:1815-1824.
  51. Johnson H, Novack DE, Adler BL, et al. Can atopic dermatitis and allergic contact dermatitis coexist? Cutis. 2022;110:139-142. doi:10.12788cutis.0599
  52. Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs. 2004;6:233-250. doi:10.2165/00148581-200406040-00003
  53. Singh A, Kansal NK, Kumawat D, et al. Ophthalmic manifestations of seborrheic dermatitis. Skinmed. 2023;21:397-401.
  54. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91:185-190.
  55. Lachapelle JM, Maibach HI. Patch Testing and Prick Testing. Springer; 2012.
  56. Fregert S. Manual of Contact Dermatitis: On Behalf of the International Contact Dermatitis Research Group. Munksgaard; 1974.
  57. Reeder M, Reck Atwater A. Patch testing 101, part 1: performing the test. Cutis. 2020;106:165-167. doi:10.12788/cutis.0093
  58. Wolf R, Perluk H. Failure of routine patch test results to detect eyelid dermatitis. Cutis. 1992;49:133-134.
  59. Grey KR, Warshaw EM. Allergic contact dermatitis to ophthalmic medications: relevant allergens and alternative testing methods. Dermat Contact Atopic Occup Drug. 2016;27:333-347. doi:10.1097/DER.0000000000000224
Article PDF
Author and Disclosure Information

Mykayla Sandler and Dr. Yu are from the Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston. Ivan Rodriguez and Dr. Adler are from the Keck School of Medicine, University of Southern California, Los Angeles. Dr. Adler is from the Department of Dermatology.

Mykayla Sandler and Ivan Rodriguez have no relevant financial disclosures to report. Dr. Adler has served as a research investigator and/or consultant for AbbVie and Dermavant. Dr. Yu has served as a consultant, advisory board member, and/or investigator for Abbvie, Arcutis, Astria, Dermavant, Dynamed, Eli Lilly & Company, Incyte, iRhythm, LEO Pharma, National Eczema Association, O’Glacee, Pfizer, Sanofi, SmartPractice, and Sol-Gel. He also receives honorarium from UptoDate; has received research grants from the Dermatology Foundation and PedRA; and is the Director and President-elect of the American Contact Dermatitis Society.

Correspondence: JiaDe Yu, MD, MS, Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, Ste 200, Boston, MA 02114 (jdyu@mgb.org).

Cutis. 2024 October;114(4):104-108. doi:10.12788/cutis.1113

Publications
Topics
Page Number
104-108
Sections
Author and Disclosure Information

Mykayla Sandler and Dr. Yu are from the Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston. Ivan Rodriguez and Dr. Adler are from the Keck School of Medicine, University of Southern California, Los Angeles. Dr. Adler is from the Department of Dermatology.

Mykayla Sandler and Ivan Rodriguez have no relevant financial disclosures to report. Dr. Adler has served as a research investigator and/or consultant for AbbVie and Dermavant. Dr. Yu has served as a consultant, advisory board member, and/or investigator for Abbvie, Arcutis, Astria, Dermavant, Dynamed, Eli Lilly & Company, Incyte, iRhythm, LEO Pharma, National Eczema Association, O’Glacee, Pfizer, Sanofi, SmartPractice, and Sol-Gel. He also receives honorarium from UptoDate; has received research grants from the Dermatology Foundation and PedRA; and is the Director and President-elect of the American Contact Dermatitis Society.

Correspondence: JiaDe Yu, MD, MS, Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, Ste 200, Boston, MA 02114 (jdyu@mgb.org).

Cutis. 2024 October;114(4):104-108. doi:10.12788/cutis.1113

Author and Disclosure Information

Mykayla Sandler and Dr. Yu are from the Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston. Ivan Rodriguez and Dr. Adler are from the Keck School of Medicine, University of Southern California, Los Angeles. Dr. Adler is from the Department of Dermatology.

Mykayla Sandler and Ivan Rodriguez have no relevant financial disclosures to report. Dr. Adler has served as a research investigator and/or consultant for AbbVie and Dermavant. Dr. Yu has served as a consultant, advisory board member, and/or investigator for Abbvie, Arcutis, Astria, Dermavant, Dynamed, Eli Lilly & Company, Incyte, iRhythm, LEO Pharma, National Eczema Association, O’Glacee, Pfizer, Sanofi, SmartPractice, and Sol-Gel. He also receives honorarium from UptoDate; has received research grants from the Dermatology Foundation and PedRA; and is the Director and President-elect of the American Contact Dermatitis Society.

Correspondence: JiaDe Yu, MD, MS, Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, Ste 200, Boston, MA 02114 (jdyu@mgb.org).

Cutis. 2024 October;114(4):104-108. doi:10.12788/cutis.1113

Article PDF
Article PDF

Eyelid dermatitis is a common dermatologic concern representing a broad group of inflammatory dermatoses and typically presenting as eczematous lesions on the eyelids.1 One of the most common causes of eyelid dermatitis is thought to be allergic contact dermatitis (ACD), a type IV delayed hypersensitivity reaction caused by exposure to external allergens.2 Although ACD can occur anywhere on the body, dermatitis on the face and eyelids is quite common.1,2 This article aims to explore the clinical manifestation, evaluation, and management of eyelid ACD.

Pathophysiology of Eyelid ACD

Studies have shown that ACD is the most common cause of eyelid dermatitis, estimated to account for 46% to 72% of cases worldwide.3-6 Allergic contact dermatitis is a T cell–mediated type IV hypersensitivity reaction to external antigens that manifests as eczematous lesions at the site of contact with the allergen that may spread.7 Allergic contact dermatitis is a common condition, and it is estimated that at least 20% of the general worldwide population has a contact allergy.8,9 Histologically, ACD manifests as spongiotic dermatitis, though this is not unique and also may be seen in atopic dermatitis (AD) and irritant contact dermatitis.2 Allergic contact dermatitis is diagnosed via epicutaneous patch testing, and treatment involves allergen avoidance with or without adjuvant topical and/or systemic immunomodulatory treatments.7

The eyelids are uniquely prone to the development of ACD given their thinner epidermis and increased susceptibility to irritation. They frequently are exposed to allergens through the direct topical route as well as indirectly via airborne exposure, rinse-down products (eg, shampoos), and substances transferred from an individual’s own hands. The occluded skin folds of the eyelids facilitate increased exposure to trapped allergens.10,11 Additionally, the skin of the eyelids is thin, flexible, highly vascularized, and lacking in subcutaneous tissue, making this area more susceptible to antigen penetration than other locations on the body.1,2,10,12,13

Clinical Manifestations

Eyelid ACD is more common in females than males, which is thought to be related to increased use of cosmetics and fragrances.1,3,12,14-16 Clinical manifestations may resemble eczematous papules and plaques.1 Eyelid ACD commonly spreads beyond the eyelid margin, which helps to differentiate it from AD and irritant contact dermatitis. Symptoms of ACD on the eyelids typically include pruritus, redness, swelling, tearing, scaling, and pain.2 Persistent untreated eyelid dermatitis can lead to eyelash loss, damage to meibomian glands, and hyperpigmentation.2,17,18

Patterns of Eyelid ACD

Allergic contact dermatitis on the eyelids can occur due to direct application of allergens onto the skin of the eyelids, runoff of products from the hair/scalp (eg, shampoo), transfer of allergens from the hands, or contact with airborne allergens.1,2,11,12 Some reports have suggested that eyelid ACD more often is caused by products applied to the scalp or face rather than those applied directly to the eyelids.11 Because the scalp and face are less reactive to contact allergens, in some cases the eyelids may be the only affected site.10,12,13

The specific pattern of dermatitis on or around the eyelids can provide clues to the allergenic source. Dermatitis present around the eyelids and periorbital region with involvement of the bilateral upper and lower eyelids suggests direct exposure to a contact allergen, such as makeup or other cosmetic products.1 Unilateral involvement of only 1 eyelid can occur with ectopic transfer of allergens from the hands or nails.1,19 Involvement of the fingers or nails in addition to the eyelids may further suggest ectopic transfer, such as from allergens in nail polish.10 Unilateral eyelid dermatitis also could be caused by unique exposures such as a microscope or camera eyepiece.19 Distribution around the lower eyelids and upper cheeks is indicative of a drip or runoff pattern, which may result from an ophthalmic solution such as eye drops or contact lens solution.1,19 Finally, dermatitis affecting the upper eyelids along with the nasolabial folds and upper chest may suggest airborne contact dermatitis to fragrances or household cleaning products.1,11

Common Culprits of Eyelid ACD

Common causes of eyelid ACD include cosmetic products, ophthalmic medications, nail lacquers, and jewelry.10,13,20 Within the broader category of cosmetics, allergens may be found in makeup and makeup removers, cosmetic applicators and brushes, soaps and cleansers, creams and sunscreens, antiaging products, hair products, nail polish and files, and hair removal products, among many others.10,13,16,20 Additionally, ophthalmologic and topical medications are common sources of ACD, including eyedrops, contact lens solution, and topical antibiotics.10,13,21 Costume jewelry commonly contains allergenic metals, which also can be found in eyelash curlers, eyeglasses, toys, and other household items.22,23 Finally, contact allergens can be found in items such as goggles, gloves, textiles, and a variety of other occupational and household exposures.

Allergic contact dermatitis of the eyelids occurs predominantly—but not exclusively—in females.16,20,24 This finding has been attributed to the traditionally greater use of cosmetics and fragrances among women; however, the use of skin care products among men is increasing, and recent studies have shown the eyelids to be a common location of facial contact dermatitis among men.16,24 Although eyelid dermatitis has not been specifically analyzed by sex, a retrospective analysis of 1332 male patients with facial dermatitis found the most common sites to be the face (not otherwise specified)(48.9%), eyelids (23.5%), and lips (12.6%). In this cohort, the most common allergens were surfactants in shampoos and paraphenylenediamine in hair dyes.24

Common Allergens

Common contact allergens among patients with ACD of the eyelids include metals, fragrances, preservatives, acrylates, and topical medications.3,10,16,20,25-27 Sources of common contact allergens are reviewed in Table 1.

Metals—Metals are among the most common causes of ACD overall, and nickel frequently is reported as one of the top contact allergens in patients with eyelid dermatitis.16,27 A retrospective analysis of 2332 patients with eyelid dermatitis patch tested by the North American Contact Dermatitis Group from 1994 to 2016 found that 18.6% of patients with eyelid ACD had a clinically relevant nickel allergy. Sources of nickel exposure include jewelry, grooming devices, makeup and makeup applicators, and eyelash curlers, as well as direct transfer from the hands after contact with consumer products.16

Other metals that can cause ACD include cobalt (found in similar products to nickel) and gold. Gold often is associated with eyelid dermatitis, though its clinical relevance has been debated, as gold is a relatively inert metal that rarely is present in eye cosmetics and its ions are not displaced from objects and deposited on the skin via sweat in the same way as nickel.4,16,20,28-30 Despite this, studies have shown that gold is a common positive patch test reaction among patients with eyelid dermatitis, even in patients with no dermatitis at the site of contact with gold jewelry.20,29,31 Gold has been reported to be the most common allergen causing unilateral eyelid dermatitis via ectopic transfer.16,19,20,29 It has been proposed that titanium dioxide, present in many cosmetics and sunscreens, displaces gold allowing its release from jewelry, thereby liberating the fine gold ions and allowing them to desposit on the face and eyelids.30,31 Given the uncertain clinical relevance of positive patch test reactions to gold, Warshaw at al16 recommend a 2- to 3-month trial of gold jewelry avoidance to establish relevance, and Ehrlich and Gold29 noted that avoidance of gold leads to improvement.

Fragrances—Fragrances represent a broad category of naturally occurring and man-made components that often are combined to produce a desired scent in personal care products.32 Essential oils and botanicals are both examples of natural fragrances.33 Fragrances are found in numerous products including makeup, hair products, and household cleaning supplies and represent some of the most common contact allergens.32 Common fragrance allergens include fragrance mixes I and II, hydroperoxides of linalool, and balsam of Peru.12,32,34 Allergic contact dermatitis to fragrances typically manifests on the eyelids, face, or hands.33 Several studies have found fragrances to be among the top contact allergens in patients with eyelid dermatitis.3,12,20,25,34 Patch testing for fragrance allergy may include baseline series, supplemental fragrance series, and personal care products.32,35

Preservatives—Preservatives, including formaldehyde and formaldehyde releasers (eg, quaternium-15 and ­bronopol) and methylchloroisothiazolinone/­methylisothiazolinone, may be found in personal care products such as makeup, makeup removers, emollients, shampoos, hair care products, and ophthalmologic solutions and are among the most common cosmetic sources of ACD.13,36-39 Preservatives are among the top allergens causing eyelid dermatitis.20 In particular, patch test positivity rates to methylchloroisothiazolinone/methylisothiazolinone have been increasing in North America.40 Sensitization to preservatives may occur through direct skin contact or transfer from the hands.41

Acrylates—Acrylates are compounds derived from acrylic acid that may be found in acrylic and gel nails, eyelash extensions, and other adhesives and are frequent causes of eyelid ACD.4,10,42 Acrylate exposure may be cosmetic among consumers or occupational (eg, aestheticians).42,43 Acrylates on the nails may cause eyelid dermatitis via ectopic transfer from the hands and also may cause periungual dermatitis manifesting as nail bed erythema.10 Hydroxyethyl methacrylate is one of the more common eyelid ACD allergens, and studies have shown increasing prevalence of positive reaction rates to hydroxyethylmethacrylate.10,44Topical Medications—Contact allergies to topical medications are quite common, estimated to occur in 10% to 17% of patients undergoing patch testing.45 Both active and inactive ingredients of topical medications may be culprits in eyelid ACD. The most common topical medication allergens include antibiotics, steroids, local anesthetics, and nonsteroidal anti-inflammatory drugs.45 Topical antibiotics such as neomycin and bacitracin represent some of the most common causes of eyelid dermatitis4,10 and may be found in a variety of products, including antibacterial ointments and eye drops.1 Many ophthalmologic medications also contain corticosteroids, with the most common allergenic steroids being tixocortol pivalate (a marker for hydrocortisone allergy) and budesonide.10,20 Topical steroids pose a particular dilemma, as they can be either the source of or a treatment for ACD.10 Eye drops also may contain anesthetics, β-blockers, and antihistamines, as well as the preservative benzalkonium chloride, all of which may be contact allergens.21,39

Differential Diagnosis of Eyelid Dermatitis

Although ACD is reported to be the most common cause of eyelid dermatitis, the differential diagnosis is broad, including endogenous inflammatory dermatoses and exogenous exposures (Table 2). Symptoms of eyelid ACD can be nonspecific (eg, erythema, pruritus), making diagnosis challenging.46

Atopic dermatitis represents another common cause of eyelid dermatitis, accounting for 14% to 39.5% of cases.3-5,49Atopic dermatitis of the eyelids classically manifests with lichenification of the medial aspects of the eyelids.50 Atopic dermatitis and ACD may be difficult to distinguish, as the 2 conditions appear clinically similar and can develop concomitantly.51 Additionally, atopic patients are likely to have comorbid allergic rhinitis and sensitivity to environmental allergens, which may lead to chronic eye scratching and lichenification.1,51 Clinical features of eyelid dermatitis suggesting allergic rhinitis and likely comorbid AD include creases in the lower eyelids (Dennie-Morgan lines) and periorbital hyperpigmentation (known as the allergic shiner) due to venous congestion.1,52

Seborrheic dermatitis is an inflammatory reaction to Malassezia yeast that occurs in sebaceous areas such as the groin, scalp, eyebrows, eyelids, and nasolabial folds.1,53,54

Irritant contact dermatitis, a nonspecific inflammatory reaction caused by direct cell damage from external irritants, also may affect the eyelids and appear similar to ACD.1 It typically manifests with a burning or stinging sensation, as opposed to pruritus, and generally develops and resolves more rapidly than ACD.1 Personal care products are common causes of eyelid irritant contact dermatitis.16

Patch Testing for Eyelid ACD

The gold standard for diagnosis of ACD is patch testing, outlined by the International Contact Dermatitis Research Group.55-57 Patch testing generally is performed with standardized panels of allergens and can be customized either with supplemental panels based on unique exposures or with the patient’s own personal care products to increase the sensitivity of testing. Therefore, a thorough history is crucial to identifying potential allergens in a patient’s environment.

False negatives are possible, as the skin on the back may be thicker and less sensitive than the skin at the location of dermatitis.2,58 This is particularly relevant when using patch testing to diagnose ACD of the eyelids, where the skin is particularly thin and sensitive.2 Additionally, ingredients of ophthalmic medications are known to have an especially high false-negative rate with standard patch testing and may require repeated testing with higher drug concentrations or modified patch testing procedures (eg, open testing, scratch-patch testing).1,59

Treatment

Management of ACD involves allergen avoidance, typically dictated by patch test results.10 Allergen avoidance may be facilitated using online resources such as the Contact Allergen Management Program (https://www.acdscamp.org/) created by the American Contact Dermatitis Society.10,18 Patient counseling following patch testing is crucial to educating patients about sources of potential allergen exposures and strategies for avoidance. In the case of eyelid dermatitis, it is particularly important to consider exposure to airborne allergens such as fragrances.16 Fragrance avoidance is uniquely difficult, as labelling standards in the United States currently do not require disclosure of specific fragrance components.33 Additionally, products labelled as unscented may still contain fragrances. As such, some patients with fragrance allergy may need to carefully avoid all products containing fragrances.33

In addition to allergen avoidance, eyelid ACD may be treated with topical medications (eg, steroids, calcineurin inhibitors, Janus kinase inhibitors); however, these same topical medications also can cause ACD due to some ingredients such as propylene glycol.10 Topical steroids should be used with caution on the eyelids given the risk for atrophy, cataracts, and glaucoma.1

Final Interpretation

Eyelid dermatitis is a common dermatologic condition most frequently caused by ACD due to exposure to allergens in cosmetic products, ophthalmic medications, nail lacquers, and jewelry, among many other potential sources. The most common allergens causing eyelid dermatitis include metals (particularly nickel), fragrances, preservatives, acrylates, and topical medications. Eyelid ACD is diagnosed via patch testing, and the mainstay of treatment is strict allergen avoidance. Patient counseling is vital for successful allergen avoidance and resolution of eyelid ACD.

Eyelid dermatitis is a common dermatologic concern representing a broad group of inflammatory dermatoses and typically presenting as eczematous lesions on the eyelids.1 One of the most common causes of eyelid dermatitis is thought to be allergic contact dermatitis (ACD), a type IV delayed hypersensitivity reaction caused by exposure to external allergens.2 Although ACD can occur anywhere on the body, dermatitis on the face and eyelids is quite common.1,2 This article aims to explore the clinical manifestation, evaluation, and management of eyelid ACD.

Pathophysiology of Eyelid ACD

Studies have shown that ACD is the most common cause of eyelid dermatitis, estimated to account for 46% to 72% of cases worldwide.3-6 Allergic contact dermatitis is a T cell–mediated type IV hypersensitivity reaction to external antigens that manifests as eczematous lesions at the site of contact with the allergen that may spread.7 Allergic contact dermatitis is a common condition, and it is estimated that at least 20% of the general worldwide population has a contact allergy.8,9 Histologically, ACD manifests as spongiotic dermatitis, though this is not unique and also may be seen in atopic dermatitis (AD) and irritant contact dermatitis.2 Allergic contact dermatitis is diagnosed via epicutaneous patch testing, and treatment involves allergen avoidance with or without adjuvant topical and/or systemic immunomodulatory treatments.7

The eyelids are uniquely prone to the development of ACD given their thinner epidermis and increased susceptibility to irritation. They frequently are exposed to allergens through the direct topical route as well as indirectly via airborne exposure, rinse-down products (eg, shampoos), and substances transferred from an individual’s own hands. The occluded skin folds of the eyelids facilitate increased exposure to trapped allergens.10,11 Additionally, the skin of the eyelids is thin, flexible, highly vascularized, and lacking in subcutaneous tissue, making this area more susceptible to antigen penetration than other locations on the body.1,2,10,12,13

Clinical Manifestations

Eyelid ACD is more common in females than males, which is thought to be related to increased use of cosmetics and fragrances.1,3,12,14-16 Clinical manifestations may resemble eczematous papules and plaques.1 Eyelid ACD commonly spreads beyond the eyelid margin, which helps to differentiate it from AD and irritant contact dermatitis. Symptoms of ACD on the eyelids typically include pruritus, redness, swelling, tearing, scaling, and pain.2 Persistent untreated eyelid dermatitis can lead to eyelash loss, damage to meibomian glands, and hyperpigmentation.2,17,18

Patterns of Eyelid ACD

Allergic contact dermatitis on the eyelids can occur due to direct application of allergens onto the skin of the eyelids, runoff of products from the hair/scalp (eg, shampoo), transfer of allergens from the hands, or contact with airborne allergens.1,2,11,12 Some reports have suggested that eyelid ACD more often is caused by products applied to the scalp or face rather than those applied directly to the eyelids.11 Because the scalp and face are less reactive to contact allergens, in some cases the eyelids may be the only affected site.10,12,13

The specific pattern of dermatitis on or around the eyelids can provide clues to the allergenic source. Dermatitis present around the eyelids and periorbital region with involvement of the bilateral upper and lower eyelids suggests direct exposure to a contact allergen, such as makeup or other cosmetic products.1 Unilateral involvement of only 1 eyelid can occur with ectopic transfer of allergens from the hands or nails.1,19 Involvement of the fingers or nails in addition to the eyelids may further suggest ectopic transfer, such as from allergens in nail polish.10 Unilateral eyelid dermatitis also could be caused by unique exposures such as a microscope or camera eyepiece.19 Distribution around the lower eyelids and upper cheeks is indicative of a drip or runoff pattern, which may result from an ophthalmic solution such as eye drops or contact lens solution.1,19 Finally, dermatitis affecting the upper eyelids along with the nasolabial folds and upper chest may suggest airborne contact dermatitis to fragrances or household cleaning products.1,11

Common Culprits of Eyelid ACD

Common causes of eyelid ACD include cosmetic products, ophthalmic medications, nail lacquers, and jewelry.10,13,20 Within the broader category of cosmetics, allergens may be found in makeup and makeup removers, cosmetic applicators and brushes, soaps and cleansers, creams and sunscreens, antiaging products, hair products, nail polish and files, and hair removal products, among many others.10,13,16,20 Additionally, ophthalmologic and topical medications are common sources of ACD, including eyedrops, contact lens solution, and topical antibiotics.10,13,21 Costume jewelry commonly contains allergenic metals, which also can be found in eyelash curlers, eyeglasses, toys, and other household items.22,23 Finally, contact allergens can be found in items such as goggles, gloves, textiles, and a variety of other occupational and household exposures.

Allergic contact dermatitis of the eyelids occurs predominantly—but not exclusively—in females.16,20,24 This finding has been attributed to the traditionally greater use of cosmetics and fragrances among women; however, the use of skin care products among men is increasing, and recent studies have shown the eyelids to be a common location of facial contact dermatitis among men.16,24 Although eyelid dermatitis has not been specifically analyzed by sex, a retrospective analysis of 1332 male patients with facial dermatitis found the most common sites to be the face (not otherwise specified)(48.9%), eyelids (23.5%), and lips (12.6%). In this cohort, the most common allergens were surfactants in shampoos and paraphenylenediamine in hair dyes.24

Common Allergens

Common contact allergens among patients with ACD of the eyelids include metals, fragrances, preservatives, acrylates, and topical medications.3,10,16,20,25-27 Sources of common contact allergens are reviewed in Table 1.

Metals—Metals are among the most common causes of ACD overall, and nickel frequently is reported as one of the top contact allergens in patients with eyelid dermatitis.16,27 A retrospective analysis of 2332 patients with eyelid dermatitis patch tested by the North American Contact Dermatitis Group from 1994 to 2016 found that 18.6% of patients with eyelid ACD had a clinically relevant nickel allergy. Sources of nickel exposure include jewelry, grooming devices, makeup and makeup applicators, and eyelash curlers, as well as direct transfer from the hands after contact with consumer products.16

Other metals that can cause ACD include cobalt (found in similar products to nickel) and gold. Gold often is associated with eyelid dermatitis, though its clinical relevance has been debated, as gold is a relatively inert metal that rarely is present in eye cosmetics and its ions are not displaced from objects and deposited on the skin via sweat in the same way as nickel.4,16,20,28-30 Despite this, studies have shown that gold is a common positive patch test reaction among patients with eyelid dermatitis, even in patients with no dermatitis at the site of contact with gold jewelry.20,29,31 Gold has been reported to be the most common allergen causing unilateral eyelid dermatitis via ectopic transfer.16,19,20,29 It has been proposed that titanium dioxide, present in many cosmetics and sunscreens, displaces gold allowing its release from jewelry, thereby liberating the fine gold ions and allowing them to desposit on the face and eyelids.30,31 Given the uncertain clinical relevance of positive patch test reactions to gold, Warshaw at al16 recommend a 2- to 3-month trial of gold jewelry avoidance to establish relevance, and Ehrlich and Gold29 noted that avoidance of gold leads to improvement.

Fragrances—Fragrances represent a broad category of naturally occurring and man-made components that often are combined to produce a desired scent in personal care products.32 Essential oils and botanicals are both examples of natural fragrances.33 Fragrances are found in numerous products including makeup, hair products, and household cleaning supplies and represent some of the most common contact allergens.32 Common fragrance allergens include fragrance mixes I and II, hydroperoxides of linalool, and balsam of Peru.12,32,34 Allergic contact dermatitis to fragrances typically manifests on the eyelids, face, or hands.33 Several studies have found fragrances to be among the top contact allergens in patients with eyelid dermatitis.3,12,20,25,34 Patch testing for fragrance allergy may include baseline series, supplemental fragrance series, and personal care products.32,35

Preservatives—Preservatives, including formaldehyde and formaldehyde releasers (eg, quaternium-15 and ­bronopol) and methylchloroisothiazolinone/­methylisothiazolinone, may be found in personal care products such as makeup, makeup removers, emollients, shampoos, hair care products, and ophthalmologic solutions and are among the most common cosmetic sources of ACD.13,36-39 Preservatives are among the top allergens causing eyelid dermatitis.20 In particular, patch test positivity rates to methylchloroisothiazolinone/methylisothiazolinone have been increasing in North America.40 Sensitization to preservatives may occur through direct skin contact or transfer from the hands.41

Acrylates—Acrylates are compounds derived from acrylic acid that may be found in acrylic and gel nails, eyelash extensions, and other adhesives and are frequent causes of eyelid ACD.4,10,42 Acrylate exposure may be cosmetic among consumers or occupational (eg, aestheticians).42,43 Acrylates on the nails may cause eyelid dermatitis via ectopic transfer from the hands and also may cause periungual dermatitis manifesting as nail bed erythema.10 Hydroxyethyl methacrylate is one of the more common eyelid ACD allergens, and studies have shown increasing prevalence of positive reaction rates to hydroxyethylmethacrylate.10,44Topical Medications—Contact allergies to topical medications are quite common, estimated to occur in 10% to 17% of patients undergoing patch testing.45 Both active and inactive ingredients of topical medications may be culprits in eyelid ACD. The most common topical medication allergens include antibiotics, steroids, local anesthetics, and nonsteroidal anti-inflammatory drugs.45 Topical antibiotics such as neomycin and bacitracin represent some of the most common causes of eyelid dermatitis4,10 and may be found in a variety of products, including antibacterial ointments and eye drops.1 Many ophthalmologic medications also contain corticosteroids, with the most common allergenic steroids being tixocortol pivalate (a marker for hydrocortisone allergy) and budesonide.10,20 Topical steroids pose a particular dilemma, as they can be either the source of or a treatment for ACD.10 Eye drops also may contain anesthetics, β-blockers, and antihistamines, as well as the preservative benzalkonium chloride, all of which may be contact allergens.21,39

Differential Diagnosis of Eyelid Dermatitis

Although ACD is reported to be the most common cause of eyelid dermatitis, the differential diagnosis is broad, including endogenous inflammatory dermatoses and exogenous exposures (Table 2). Symptoms of eyelid ACD can be nonspecific (eg, erythema, pruritus), making diagnosis challenging.46

Atopic dermatitis represents another common cause of eyelid dermatitis, accounting for 14% to 39.5% of cases.3-5,49Atopic dermatitis of the eyelids classically manifests with lichenification of the medial aspects of the eyelids.50 Atopic dermatitis and ACD may be difficult to distinguish, as the 2 conditions appear clinically similar and can develop concomitantly.51 Additionally, atopic patients are likely to have comorbid allergic rhinitis and sensitivity to environmental allergens, which may lead to chronic eye scratching and lichenification.1,51 Clinical features of eyelid dermatitis suggesting allergic rhinitis and likely comorbid AD include creases in the lower eyelids (Dennie-Morgan lines) and periorbital hyperpigmentation (known as the allergic shiner) due to venous congestion.1,52

Seborrheic dermatitis is an inflammatory reaction to Malassezia yeast that occurs in sebaceous areas such as the groin, scalp, eyebrows, eyelids, and nasolabial folds.1,53,54

Irritant contact dermatitis, a nonspecific inflammatory reaction caused by direct cell damage from external irritants, also may affect the eyelids and appear similar to ACD.1 It typically manifests with a burning or stinging sensation, as opposed to pruritus, and generally develops and resolves more rapidly than ACD.1 Personal care products are common causes of eyelid irritant contact dermatitis.16

Patch Testing for Eyelid ACD

The gold standard for diagnosis of ACD is patch testing, outlined by the International Contact Dermatitis Research Group.55-57 Patch testing generally is performed with standardized panels of allergens and can be customized either with supplemental panels based on unique exposures or with the patient’s own personal care products to increase the sensitivity of testing. Therefore, a thorough history is crucial to identifying potential allergens in a patient’s environment.

False negatives are possible, as the skin on the back may be thicker and less sensitive than the skin at the location of dermatitis.2,58 This is particularly relevant when using patch testing to diagnose ACD of the eyelids, where the skin is particularly thin and sensitive.2 Additionally, ingredients of ophthalmic medications are known to have an especially high false-negative rate with standard patch testing and may require repeated testing with higher drug concentrations or modified patch testing procedures (eg, open testing, scratch-patch testing).1,59

Treatment

Management of ACD involves allergen avoidance, typically dictated by patch test results.10 Allergen avoidance may be facilitated using online resources such as the Contact Allergen Management Program (https://www.acdscamp.org/) created by the American Contact Dermatitis Society.10,18 Patient counseling following patch testing is crucial to educating patients about sources of potential allergen exposures and strategies for avoidance. In the case of eyelid dermatitis, it is particularly important to consider exposure to airborne allergens such as fragrances.16 Fragrance avoidance is uniquely difficult, as labelling standards in the United States currently do not require disclosure of specific fragrance components.33 Additionally, products labelled as unscented may still contain fragrances. As such, some patients with fragrance allergy may need to carefully avoid all products containing fragrances.33

In addition to allergen avoidance, eyelid ACD may be treated with topical medications (eg, steroids, calcineurin inhibitors, Janus kinase inhibitors); however, these same topical medications also can cause ACD due to some ingredients such as propylene glycol.10 Topical steroids should be used with caution on the eyelids given the risk for atrophy, cataracts, and glaucoma.1

Final Interpretation

Eyelid dermatitis is a common dermatologic condition most frequently caused by ACD due to exposure to allergens in cosmetic products, ophthalmic medications, nail lacquers, and jewelry, among many other potential sources. The most common allergens causing eyelid dermatitis include metals (particularly nickel), fragrances, preservatives, acrylates, and topical medications. Eyelid ACD is diagnosed via patch testing, and the mainstay of treatment is strict allergen avoidance. Patient counseling is vital for successful allergen avoidance and resolution of eyelid ACD.

References
  1. Hine AM, Waldman RA, Grzybowski A, et al. Allergic disorders of the eyelid. Clin Dermatol. 2023;41:476-480. doi:10.1016/j.clindermatol.2023.08.002
  2. Turkiewicz M, Shah A, Yang YW, et al. Allergic contact dermatitis of the eyelids: an interdisciplinary review. Ocul Surf. 2023;28:124-130. doi:10.1016/j.jtos.2023.03.001
  3. Valsecchi R, Imberti G, Martino D, et al. Eyelid dermatitis: an evaluation of 150 patients. Contact Dermatitis. 1992;27:143-147. doi:10.1111/j.1600-0536.1992.tb05242.x
  4. Guin JD. Eyelid dermatitis: experience in 203 cases. J Am Acad Dermatol. 2002;47:755-765. doi:10.1067/mjd.2002.122736
  5. Nethercott JR, Nield G, Holness DL. A review of 79 cases of eyelid dermatitis. J Am Acad Dermatol. 1989;21(2 pt 1):223-230. doi:10.1016/s0190-9622(89)70165-1
  6. Shah M, Lewis FM, Gawkrodger DJ. Facial dermatitis and eyelid dermatitis: a comparison of patch test results and final diagnoses. Contact Dermatitis. 1996;34:140-141. doi:10.1111/j.1600-0536.1996.tb02148.x
  7. Brites GS, Ferreira I, Sebastião AI, et al. Allergic contact dermatitis: from pathophysiology to development of new preventive strategies. Pharmacol Res. 2020;162:105282. doi:10.1016/j.phrs.2020.105282
  8. Alinaghi F, Bennike NH, Egeberg A, et al. Prevalence of contact allergy in the general population: a systematic review and meta-analysis. Contact Dermatitis. 2019;80:77-85. doi:10.1111/cod.13119
  9. Adler BL, DeLeo VA. Allergic contact dermatitis. JAMA Dermatol. 2021;157:364. doi:10.1001/jamadermatol.2020.5639
  10. Huang CX, Yiannias JA, Killian JM, et al. Seven common allergen groups causing eyelid dermatitis: education and avoidance strategies. Clin Ophthalmol Auckl NZ. 2021;15:1477-1490. doi:10.2147/OPTH.S297754
  11. Rozas-Muñoz E, Gamé D, Serra-Baldrich E. Allergic contact dermatitis by anatomical regions: diagnostic clues. Actas Dermo-Sifiliográficas Engl Ed. 2018;109:485-507. doi:10.1016/j.adengl.2018.05.016
  12. Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis. 2006;55:280-285. doi:10.1111/j.1600-0536.2006.00927.x
  13. Wolf R, Orion E, Tüzün Y. Periorbital (eyelid) dermatides. Clin Dermatol. 2014;32:131-140. doi:10.1016/j.clindermatol.2013.05.035
  14. Ockenfels HM, Seemann U, Goos M. Contact allergy in patients with periorbital eczema: an analysis of allergens. data recorded by the Information Network of the Departments of Dermatology. Dermatol Basel Switz. 1997;195:119-124. doi:10.1159/000245712
  15. Landeck L, John SM, Geier J. Periorbital dermatitis in 4779 patients—patch test results during a 10-year period. Contact Dermatitis. 2014;70:205-212. doi:10.1111/cod.12157
  16. Warshaw EM, Voller LM, Maibach HI, et al. Eyelid dermatitis in patients referred for patch testing: retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. J Am Acad Dermatol. 2021;84:953-964. doi:10.1016/j.jaad.2020.07.020
  17. McMonnies CW. Management of chronic habits of abnormal eye rubbing. Contact Lens Anterior Eye. 2008;31:95-102. doi:10.1016/j.clae.2007.07.008
  18. Chisholm SAM, Couch SM, Custer PL. Etiology and management of allergic eyelid dermatitis. Ophthal Plast Reconstr Surg. 2017;33:248-250. doi:10.1097/IOP.0000000000000723
  19. Lewallen R, Feldman S, eds. Regional atlas of contact dermatitis. The Dermatologist. Accessed April 22, 2024. https://s3.amazonaws.com/HMP/hmp_ln/imported/Regional%20Atlas%20of%20Contact%20Dermatitis%20Book_lr.pdf
  20. Rietschel RL, Warshaw EM, Sasseville D, et al. Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period. Dermat Contact Atopic Occup Drug. 2007;18:78-81. doi:10.2310/6620.2007.06041
  21. Mughal AA, Kalavala M. Contact dermatitis to ophthalmic solutions. Clin Exp Dermatol. 2012;37:593-597; quiz 597-598. doi:10.1111/j.1365-2230.2012.04398.x
  22. Goossens A. Contact allergic reactions on the eyes and eyelids. Bull Soc Belge Ophtalmol. 2004;292:11-17.
  23. Silverberg NB, Pelletier JL, Jacob SE, et al. Nickel allergic contact dermatitis: identification, treatment, and prevention. Pediatrics. 2020;145:E20200628. doi:10.1542/peds.2020-0628
  24. Warshaw EM, Schlarbaum JP, Maibach HI, et al. Facial dermatitis in male patients referred for patch testing. JAMA Dermatol. 2020;156:79-84. doi:10.1001/jamadermatol.2019.3531
  25. Wenk KS, Ehrlich A. Fragrance series testing in eyelid dermatitis. Dermatitis. 2012;23:22-26. doi:10.1097/DER.0b013e31823d180f
  26. Crouse L, Ziemer C, Ziemer C, et al. Trends in eyelid dermatitis. Dermat Contact Atopic Occup Drug. 2018;29:96-97. doi:10.1097/DER.0000000000000338
  27. Yazdanparast T, Nassiri Kashani M, Shamsipour M, et al. Contact allergens responsible for eyelid dermatitis in adults. J Dermatol. 2024;51:691-695. doi:10.1111/1346-8138.17140
  28. Fowler J, Taylor J, Storrs F, et al. Gold allergy in North America. Am J Contact Dermat. 2001;12:3-5.
  29. Ehrlich A, Belsito DV. Allergic contact dermatitis to gold. Cutis. 2000;65:323-326.
  30. Danesh M, Murase JE. Titanium dioxide induces eyelid dermatitis in patients allergic to gold. J Am Acad Dermatol. 2015;73:E21. doi:10.1016/j.jaad.2015.03.046
  31. Katta R. Common misconceptions in contact dermatitis counseling. Dermatol Online J. 2008;14:2.
  32. De Groot AC. Fragrances: contact allergy and other adverse effects. Dermatitis. 2020;31:13-35. doi:10.1097/DER.0000000000000463
  33. Reeder MJ. Allergic contact dermatitis to fragrances. Dermatol Clin. 2020;38:371-377. doi:10.1016/j.det.2020.02.009
  34. Warshaw EM, Zhang AJ, DeKoven JG, et al. Epidemiology of nickel sensitivity: retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014. J Am Acad Dermatol. 2019;80:701-713. doi:10.1016/j.jaad.2018.09.058
  35. Schalock PC, Dunnick CA, Nedorost S, et al. American Contact Dermatitis Society core allergen series: 2020 update. Dermatitis. 2020;31:279-282. doi:10.1097/DER.0000000000000621
  36. Yim E, Baquerizo Nole KL, Tosti A. Contact dermatitis caused by preservatives. Dermatitis. 2014;25:215-231. doi:10.1097/DER.0000000000000061
  37. Alani JI, Davis MDP, Yiannias JA. Allergy to cosmetics. Dermatitis. 2013;24:283-290. doi:10.1097/DER.0b013e3182a5d8bc
  38. Hamilton T, de Gannes GC. Allergic contact dermatitis to preservatives and fragrances in cosmetics. Skin Ther Lett. 2011;16:1-4.
  39. Ashton SJ, Mughal AA. Contact dermatitis to ophthalmic solutions: an update. Dermat Contact Atopic Occup Drug. 2023;34:480-483. doi:10.1089/derm.2023.0033
  40. Reeder MJ, Warshaw E, Aravamuthan S, et al. Trends in the prevalence of methylchloroisothiazolinone/methylisothiazolinone contact allergy in North America and Europe. JAMA Dermatol. 2023;159:267-274. doi:10.1001/jamadermatol.2022.5991
  41. Herro EM, Elsaie ML, Nijhawan RI, et al. Recommendations for a screening series for allergic contact eyelid dermatitis. Dermatitis. 2012;23:17-21. doi:10.1097/DER.0b013e31823d191f
  42. Kucharczyk M, Słowik-Rylska M, Cyran-Stemplewska S, et al. Acrylates as a significant cause of allergic contact dermatitis: new sources of exposure. Adv Dermatol Allergol Dermatol Alergol. 2021;38:555-560. doi:10.5114/ada.2020.95848
  43. Rodriguez I, George SE, Yu J, et al. Tackling acrylate allergy: the sticky truth. Cutis. 2023;112:282-286. doi:10.12788/cutis.0909
  44. DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group Patch Test Results: 2019–2020. Dermatitis. 2023;34:90-104. doi:10.1089/derm.2022.29017.jdk
  45. de Groot A. Allergic contact dermatitis from topical drugs: an overview. Dermatitis. 2021;32:197-213. doi:10.1097/DER.0000000000000737
  46. Zug KA, Palay DA, Rock B. Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol. 1996;40:293-306. doi:10.1016/s0039-6257(96)82004-2
  47. Beltrani VS. Eyelid dermatitis. Curr Allergy Asthma Rep. 2001;1:380-388. doi:10.1007/s11882-001-0052-0
  48. Hirji SH, Maeng MM, Tran AQ, et al. Cutaneous T-cell lymphoma of the eyelid masquerading as dermatitis. Orbit Amst Neth. 2021;40:75-78. doi:10.1080/01676830.2020.1739080
  49. Svensson A, Möller H. Eyelid dermatitis: the role of atopy and contact allergy. Contact Dermatitis. 1986;15:178-182. doi:10.1111/j.1600-0536.1986.tb01321.x
  50. Papier A, Tuttle DJ, Mahar TJ. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2007;76:1815-1824.
  51. Johnson H, Novack DE, Adler BL, et al. Can atopic dermatitis and allergic contact dermatitis coexist? Cutis. 2022;110:139-142. doi:10.12788cutis.0599
  52. Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs. 2004;6:233-250. doi:10.2165/00148581-200406040-00003
  53. Singh A, Kansal NK, Kumawat D, et al. Ophthalmic manifestations of seborrheic dermatitis. Skinmed. 2023;21:397-401.
  54. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91:185-190.
  55. Lachapelle JM, Maibach HI. Patch Testing and Prick Testing. Springer; 2012.
  56. Fregert S. Manual of Contact Dermatitis: On Behalf of the International Contact Dermatitis Research Group. Munksgaard; 1974.
  57. Reeder M, Reck Atwater A. Patch testing 101, part 1: performing the test. Cutis. 2020;106:165-167. doi:10.12788/cutis.0093
  58. Wolf R, Perluk H. Failure of routine patch test results to detect eyelid dermatitis. Cutis. 1992;49:133-134.
  59. Grey KR, Warshaw EM. Allergic contact dermatitis to ophthalmic medications: relevant allergens and alternative testing methods. Dermat Contact Atopic Occup Drug. 2016;27:333-347. doi:10.1097/DER.0000000000000224
References
  1. Hine AM, Waldman RA, Grzybowski A, et al. Allergic disorders of the eyelid. Clin Dermatol. 2023;41:476-480. doi:10.1016/j.clindermatol.2023.08.002
  2. Turkiewicz M, Shah A, Yang YW, et al. Allergic contact dermatitis of the eyelids: an interdisciplinary review. Ocul Surf. 2023;28:124-130. doi:10.1016/j.jtos.2023.03.001
  3. Valsecchi R, Imberti G, Martino D, et al. Eyelid dermatitis: an evaluation of 150 patients. Contact Dermatitis. 1992;27:143-147. doi:10.1111/j.1600-0536.1992.tb05242.x
  4. Guin JD. Eyelid dermatitis: experience in 203 cases. J Am Acad Dermatol. 2002;47:755-765. doi:10.1067/mjd.2002.122736
  5. Nethercott JR, Nield G, Holness DL. A review of 79 cases of eyelid dermatitis. J Am Acad Dermatol. 1989;21(2 pt 1):223-230. doi:10.1016/s0190-9622(89)70165-1
  6. Shah M, Lewis FM, Gawkrodger DJ. Facial dermatitis and eyelid dermatitis: a comparison of patch test results and final diagnoses. Contact Dermatitis. 1996;34:140-141. doi:10.1111/j.1600-0536.1996.tb02148.x
  7. Brites GS, Ferreira I, Sebastião AI, et al. Allergic contact dermatitis: from pathophysiology to development of new preventive strategies. Pharmacol Res. 2020;162:105282. doi:10.1016/j.phrs.2020.105282
  8. Alinaghi F, Bennike NH, Egeberg A, et al. Prevalence of contact allergy in the general population: a systematic review and meta-analysis. Contact Dermatitis. 2019;80:77-85. doi:10.1111/cod.13119
  9. Adler BL, DeLeo VA. Allergic contact dermatitis. JAMA Dermatol. 2021;157:364. doi:10.1001/jamadermatol.2020.5639
  10. Huang CX, Yiannias JA, Killian JM, et al. Seven common allergen groups causing eyelid dermatitis: education and avoidance strategies. Clin Ophthalmol Auckl NZ. 2021;15:1477-1490. doi:10.2147/OPTH.S297754
  11. Rozas-Muñoz E, Gamé D, Serra-Baldrich E. Allergic contact dermatitis by anatomical regions: diagnostic clues. Actas Dermo-Sifiliográficas Engl Ed. 2018;109:485-507. doi:10.1016/j.adengl.2018.05.016
  12. Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis. 2006;55:280-285. doi:10.1111/j.1600-0536.2006.00927.x
  13. Wolf R, Orion E, Tüzün Y. Periorbital (eyelid) dermatides. Clin Dermatol. 2014;32:131-140. doi:10.1016/j.clindermatol.2013.05.035
  14. Ockenfels HM, Seemann U, Goos M. Contact allergy in patients with periorbital eczema: an analysis of allergens. data recorded by the Information Network of the Departments of Dermatology. Dermatol Basel Switz. 1997;195:119-124. doi:10.1159/000245712
  15. Landeck L, John SM, Geier J. Periorbital dermatitis in 4779 patients—patch test results during a 10-year period. Contact Dermatitis. 2014;70:205-212. doi:10.1111/cod.12157
  16. Warshaw EM, Voller LM, Maibach HI, et al. Eyelid dermatitis in patients referred for patch testing: retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. J Am Acad Dermatol. 2021;84:953-964. doi:10.1016/j.jaad.2020.07.020
  17. McMonnies CW. Management of chronic habits of abnormal eye rubbing. Contact Lens Anterior Eye. 2008;31:95-102. doi:10.1016/j.clae.2007.07.008
  18. Chisholm SAM, Couch SM, Custer PL. Etiology and management of allergic eyelid dermatitis. Ophthal Plast Reconstr Surg. 2017;33:248-250. doi:10.1097/IOP.0000000000000723
  19. Lewallen R, Feldman S, eds. Regional atlas of contact dermatitis. The Dermatologist. Accessed April 22, 2024. https://s3.amazonaws.com/HMP/hmp_ln/imported/Regional%20Atlas%20of%20Contact%20Dermatitis%20Book_lr.pdf
  20. Rietschel RL, Warshaw EM, Sasseville D, et al. Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period. Dermat Contact Atopic Occup Drug. 2007;18:78-81. doi:10.2310/6620.2007.06041
  21. Mughal AA, Kalavala M. Contact dermatitis to ophthalmic solutions. Clin Exp Dermatol. 2012;37:593-597; quiz 597-598. doi:10.1111/j.1365-2230.2012.04398.x
  22. Goossens A. Contact allergic reactions on the eyes and eyelids. Bull Soc Belge Ophtalmol. 2004;292:11-17.
  23. Silverberg NB, Pelletier JL, Jacob SE, et al. Nickel allergic contact dermatitis: identification, treatment, and prevention. Pediatrics. 2020;145:E20200628. doi:10.1542/peds.2020-0628
  24. Warshaw EM, Schlarbaum JP, Maibach HI, et al. Facial dermatitis in male patients referred for patch testing. JAMA Dermatol. 2020;156:79-84. doi:10.1001/jamadermatol.2019.3531
  25. Wenk KS, Ehrlich A. Fragrance series testing in eyelid dermatitis. Dermatitis. 2012;23:22-26. doi:10.1097/DER.0b013e31823d180f
  26. Crouse L, Ziemer C, Ziemer C, et al. Trends in eyelid dermatitis. Dermat Contact Atopic Occup Drug. 2018;29:96-97. doi:10.1097/DER.0000000000000338
  27. Yazdanparast T, Nassiri Kashani M, Shamsipour M, et al. Contact allergens responsible for eyelid dermatitis in adults. J Dermatol. 2024;51:691-695. doi:10.1111/1346-8138.17140
  28. Fowler J, Taylor J, Storrs F, et al. Gold allergy in North America. Am J Contact Dermat. 2001;12:3-5.
  29. Ehrlich A, Belsito DV. Allergic contact dermatitis to gold. Cutis. 2000;65:323-326.
  30. Danesh M, Murase JE. Titanium dioxide induces eyelid dermatitis in patients allergic to gold. J Am Acad Dermatol. 2015;73:E21. doi:10.1016/j.jaad.2015.03.046
  31. Katta R. Common misconceptions in contact dermatitis counseling. Dermatol Online J. 2008;14:2.
  32. De Groot AC. Fragrances: contact allergy and other adverse effects. Dermatitis. 2020;31:13-35. doi:10.1097/DER.0000000000000463
  33. Reeder MJ. Allergic contact dermatitis to fragrances. Dermatol Clin. 2020;38:371-377. doi:10.1016/j.det.2020.02.009
  34. Warshaw EM, Zhang AJ, DeKoven JG, et al. Epidemiology of nickel sensitivity: retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014. J Am Acad Dermatol. 2019;80:701-713. doi:10.1016/j.jaad.2018.09.058
  35. Schalock PC, Dunnick CA, Nedorost S, et al. American Contact Dermatitis Society core allergen series: 2020 update. Dermatitis. 2020;31:279-282. doi:10.1097/DER.0000000000000621
  36. Yim E, Baquerizo Nole KL, Tosti A. Contact dermatitis caused by preservatives. Dermatitis. 2014;25:215-231. doi:10.1097/DER.0000000000000061
  37. Alani JI, Davis MDP, Yiannias JA. Allergy to cosmetics. Dermatitis. 2013;24:283-290. doi:10.1097/DER.0b013e3182a5d8bc
  38. Hamilton T, de Gannes GC. Allergic contact dermatitis to preservatives and fragrances in cosmetics. Skin Ther Lett. 2011;16:1-4.
  39. Ashton SJ, Mughal AA. Contact dermatitis to ophthalmic solutions: an update. Dermat Contact Atopic Occup Drug. 2023;34:480-483. doi:10.1089/derm.2023.0033
  40. Reeder MJ, Warshaw E, Aravamuthan S, et al. Trends in the prevalence of methylchloroisothiazolinone/methylisothiazolinone contact allergy in North America and Europe. JAMA Dermatol. 2023;159:267-274. doi:10.1001/jamadermatol.2022.5991
  41. Herro EM, Elsaie ML, Nijhawan RI, et al. Recommendations for a screening series for allergic contact eyelid dermatitis. Dermatitis. 2012;23:17-21. doi:10.1097/DER.0b013e31823d191f
  42. Kucharczyk M, Słowik-Rylska M, Cyran-Stemplewska S, et al. Acrylates as a significant cause of allergic contact dermatitis: new sources of exposure. Adv Dermatol Allergol Dermatol Alergol. 2021;38:555-560. doi:10.5114/ada.2020.95848
  43. Rodriguez I, George SE, Yu J, et al. Tackling acrylate allergy: the sticky truth. Cutis. 2023;112:282-286. doi:10.12788/cutis.0909
  44. DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group Patch Test Results: 2019–2020. Dermatitis. 2023;34:90-104. doi:10.1089/derm.2022.29017.jdk
  45. de Groot A. Allergic contact dermatitis from topical drugs: an overview. Dermatitis. 2021;32:197-213. doi:10.1097/DER.0000000000000737
  46. Zug KA, Palay DA, Rock B. Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol. 1996;40:293-306. doi:10.1016/s0039-6257(96)82004-2
  47. Beltrani VS. Eyelid dermatitis. Curr Allergy Asthma Rep. 2001;1:380-388. doi:10.1007/s11882-001-0052-0
  48. Hirji SH, Maeng MM, Tran AQ, et al. Cutaneous T-cell lymphoma of the eyelid masquerading as dermatitis. Orbit Amst Neth. 2021;40:75-78. doi:10.1080/01676830.2020.1739080
  49. Svensson A, Möller H. Eyelid dermatitis: the role of atopy and contact allergy. Contact Dermatitis. 1986;15:178-182. doi:10.1111/j.1600-0536.1986.tb01321.x
  50. Papier A, Tuttle DJ, Mahar TJ. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2007;76:1815-1824.
  51. Johnson H, Novack DE, Adler BL, et al. Can atopic dermatitis and allergic contact dermatitis coexist? Cutis. 2022;110:139-142. doi:10.12788cutis.0599
  52. Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs. 2004;6:233-250. doi:10.2165/00148581-200406040-00003
  53. Singh A, Kansal NK, Kumawat D, et al. Ophthalmic manifestations of seborrheic dermatitis. Skinmed. 2023;21:397-401.
  54. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91:185-190.
  55. Lachapelle JM, Maibach HI. Patch Testing and Prick Testing. Springer; 2012.
  56. Fregert S. Manual of Contact Dermatitis: On Behalf of the International Contact Dermatitis Research Group. Munksgaard; 1974.
  57. Reeder M, Reck Atwater A. Patch testing 101, part 1: performing the test. Cutis. 2020;106:165-167. doi:10.12788/cutis.0093
  58. Wolf R, Perluk H. Failure of routine patch test results to detect eyelid dermatitis. Cutis. 1992;49:133-134.
  59. Grey KR, Warshaw EM. Allergic contact dermatitis to ophthalmic medications: relevant allergens and alternative testing methods. Dermat Contact Atopic Occup Drug. 2016;27:333-347. doi:10.1097/DER.0000000000000224
Page Number
104-108
Page Number
104-108
Publications
Publications
Topics
Article Type
Display Headline
Eyelid Dermatitis: Common Patterns and Contact Allergens
Display Headline
Eyelid Dermatitis: Common Patterns and Contact Allergens
Sections
Inside the Article

Practice Points

  • Eyelid dermatitis is a common dermatologic concern representing a broad range of inflammatory dermatoses, most often caused by allergic contact dermatitis (ACD).
  • The most common contact allergens associated with eyelid dermatitis are metals (particularly nickel), fragrances, preservatives, acrylates, and topical medications, which may be found in a variety of sources, including cosmetics, ophthalmic medications, nail lacquers, and jewelry.
  • Eyelid ACD is diagnosed via patch testing, and management involves strict allergen avoidance.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Article PDF Media